The effect of heparin hydrogel embedding on glutaraldehyde fixed bovine pericardial tissues: Mechanical behavior and anticalcification potential
- 80 Downloads
Heart valve diseases remain common in industrialized countries. Bioprosthetic heart valves, introduced as free of anticoagulation therapy alternatives to mechanical substitutes. Still they suffer from long term failure due to calcification. Different treatment methods introduced to inhibit calcification, have so far been limited in success. Glycosaminoglycans (GAGs) possess properties including high negative charge, anticoagulation and anti-inflammatory activity that make them a potential solution for calcification problem. In this study, heparin hydrogel was prepared and characterized both chemically and mechanically. After that, heparin hydrogel embedded bovine pericardial tissues, fixed with glutaraldehyde, were produced and tested for their mechanical behavior and anticalcifcation potential in vitro using the constant composition model. In the calcification experiments, tissues were divided into three groups: a) Controls without treatment, b) Hydrogel treated tissues and c) Tissues with raw heparin dissolved in the calcification solution. The results showed that embedding of tissue with hydrogel had no stiffening effect on its mechanical behavior. Calcification assessment showed a significant efficacy on inhibition of calcium phosphate deposition of hydrogel treated (second group) in comparison to untreated tissues (control, first group). Calcification inhibition potential was very similar in both the second and raw heparin (third group). Histological data confirmed the obtained results, suggesting that heparin treatment is a promising anticalcification agent.
This research was supported by the People Program (Marie Curie Actions) of the European Union’s Seventh Framework Program FP7/2007-2013/ under REA grant agreement n° 317512. I also would like to thank Nikolas Papachristo very much for his help at the histology work.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Schoen FJ, Levy RJ. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res. 1999;47:439–65. https://doi.org/10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O. CrossRefGoogle Scholar
- 8.Webb CL, Schoen FJ, Flowers WE, Alfrey AC, Horton C, Levy RJ. Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3, and Ga(NO3)3 in rat subdermal model studies. Am J Pathol. 1991;138:971–81.Google Scholar
- 12.Alter SC, Metcalfe DD, Bradford TR, Schwartz LB. Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem J. 1987;248:821–7. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1148623/. CrossRefGoogle Scholar
- 14.Oosthuysen A, Zilla PP, Human PA, Schmidt CAP, Bezuidenhout D. Bioprosthetic tissue preservation by filling with a poly(acrylamide) hydrogel. Biomaterials. 2006;27:2123–30. https://doi.org/10.1016/j.biomaterials.2005.10.008.CrossRefGoogle Scholar
- 19.HB Sheehan D, Theory and practice of Histotechnology. Maryland Heights: Mosby; 1980.Google Scholar
- 20.F Carson, Histotechnology: A Self-Instructional Text. Chicago, IL: American Society for Clinical Pathology; 1990.Google Scholar
- 21.Pagoulatou E, Triantaphyllidou I-EE, Vynios DH, Papachristou DJ, Koletsis E, Deligianni D, Mavrilas D. Biomechanical and structural changes following the decellularization of bovine pericardial tissues for use as a tissue engineering scaffold. J Mater Sci Mater Med. 2012;23:1387–96. https://doi.org/10.1007/s10856-012-4620-8.CrossRefGoogle Scholar
- 26.SG Rokidi, PG Koutsoukos, D Mavrilas, SGRokidi, Mineralization of Biological and Artificial Tissues, Greece: University of Patras; 2011.Google Scholar
- 30.Connolly JM, Bakay MA, Alferiev IS, Gorman RC, Gorman JH 3rd, Kruth HS, Ashworth PE, Kutty JK, Schoen FJ, Bianco RW, Levy RJ. Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification. Ann Thorac Surg. 2011;92:858–65. https://doi.org/10.1016/j.athoracsur.2011.04.104.CrossRefGoogle Scholar
- 31.Zhou J, Jiang H, Wang D, Hu S. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification. J Heart Valve Dis. 2009;18:180–5. discussion 186.Google Scholar
- 37.Mavrilas D, Apostolaki A, Kapolos J, Koutsoukos P, Melachrinou M, Zolota V, Dougenis D. Development of bioprosthetic heart valve calcification in vitro and in animal models: morphology and composition. J Cryst Growth. 1999;205:554–62. https://doi.org/10.1016/S0022-0248(99)00277-8. CrossRefGoogle Scholar